Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular analysis of the human cytoglobin mRNA isoforms

ABSTRACT: Transcriptome of CYGB+/+ and gene-edited CYGB‐/‐ HepG2 HB cells

PROVIDER: PRJEB70417 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12357257_1.fastq.gz	Fastqsanger.gz
	ERR12357257_2.fastq.gz	Fastqsanger.gz
	ERR12357258_1.fastq.gz	Fastqsanger.gz
	ERR12357258_2.fastq.gz	Fastqsanger.gz
	ERR12357259_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

A Developmentally Prometastatic Niche in Neonatal Liver to Hepatoblastoma mediated by Cxcl1/Cxcr2 Axis

Project description:We find that various HB cell lines including HepG2 cells are consistently and considerably more tumorigenic and metastatic in the P5Tx model than in the P60Tx models. Sc-RNAseq of the P5Tx and P60Tx HepG2 models reveals that the P5Tx tumor is more hypoxic and has more activated hepatic stellate cells (aHSCs) in the tumor-surrounding liver which express significantly higher levels of Cxcl1 than those from the P60Tx model. We find these differences are developmentally present in the normal P5 and P60 liver. We show that Cxcl1/Cxcr2 axis mediates HB cell migration and is critical to HB cell survival under hypoxia. Treating HepG2 P60Tx model with recombinant CXCL1 protein induces multifocal intrahepatic and pulmonary metastasis and CXCR2 knockout in HepG2 cells abolishes their metastatic potential in the P5Tx model. Lastly, we show that in metastatic HB patient tumors there is a similar larger population of aHSCs in the tumor-surrounding liver than the localized tumors, and tumor hypoxia is significantly associated with HB patient prognosis.

2022-04-01 | GSE186335 | GEO

Targeted DNA-seq of Human HepG2 cells following editing with CRISPR/Cas9

Project description:We performed a large-scale genome-wide characterisation of indels generated following editing with CRISPR/Cas9. We used pools of sgRNAs and performed targeted capture and sequencing of the edited regions in HepG2 cells.

2018-12-13 | E-MTAB-7095 | biostudies-arrayexpress

GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling

Project description:The β-catenin mutation is frequently observed in hepatoblastoma (HB), but the underlying mechanism by which Wnt/β-catenin signaling induces HB tumor formation is unknown. We found that expression of growth regulation by estrogen in breast cancer 1 (GREB1) depends on Wnt/β-catenin signaling in HB patients. GREB1 was localized to the nucleus where it bound Smad2/3 in a competitive manner with p300 and inhibited TGFβ signaling, thereby promoting HepG2 HB cell proliferation. Forced expression of β-catenin, YAP, and c-Met induced HB-like mouse liver tumor (BYM mice), with an increase in GREB1 expression and HB markers. Depletion of GREB1 strongly suppressed marker gene expression and HB-like liver tumorigenesis, and instead enhanced TGFβ signaling in BYM mice. Furthermore, antisense oligonucleotides for GREB1 suppressed the formation of HepG2 cell-induced tumors and HB-like tumors in vivo. We propose that GREB1 is a novel target molecule of Wnt/β-catenin signaling and required for HB progression.

2019-07-18 | GSE133976 | GEO

Partners of different NHSL3 isoforms

Project description:MCF10A cells were genome edited to tag the endogenous ORF of NHSL3 and generate C-terminal GFP-Flag fusion proteins of all NHSL3 isoforms. MCF10A cells express 4 NHSL3 isoforms through the use of alternative exons (i1, i2, i3L and i3S). Plasmids encoding N-terminal Flag-GFP fusion proteins were constructed and used to select stable MCF10A cell lines expressing each of the tagged isoform. The 4 distinct NHSL3 isoforms in these stable cell lines as well as all isoforms together from the genome edited cell line were purified by Tandem Affinity Purification and associated proteins were identified by LC-MS/MS.

2025-03-04 | PXD053609 | Pride

Accurate identification and analysis of human mRNA isoforms using deep long read sequencing.

Project description: Not available

| S-EPMC3583448 | biostudies-literature

Bulk mRNA-seq analysis of LIMD1 deficient (CRISPR-Cas9 edited) human SAEC cells.

Project description:To understand mRNA abundance changes in LIMD1 deficient human SAEC cells, we performed bulk mRNA-seq on Ctrl, LIMD1 Het, and LIMD1 KO (CRISPR-Cas9 edited) hSAECs.

2026-06-23 | GSE305016 | GEO

Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene.

Project description: Not available

| S-EPMC3455135 | biostudies-literature

Bulk mRNA-seq analysis of LIMD1 deficient (CRISPR-Cas9 edited) human SAEC cells.

Project description:Bulk mRNA-seq analysis of LIMD1 deficient (CRISPR-Cas9 edited) human SAEC cells.

| PRJNA1303710 | ENA

mRNA microarray analysis on HepG2 cells exposed to amorphous Silica Nanoparticles (SiO2-NP)

Project description:In order to evaluate the identification of genes and pathways, the global gene expression profiles were assessed in response to amorphous Silica nanoparticles on Human hepatoma (HepG2) cells. We performed whole genome DNA microarray experiments using HepG2 cells exposed to for 24h. We used whole genome microarrays to screen for global changed in HepG2 transcription profiles and with subsequent quantitative analysis conducted on selected genes. 24h SiO2-NP (100 mg/L) exposed HepG2 cells were used for total RNA extraction and hybridization on Affymetrix microarrays.

2013-10-01 | E-GEOD-51276 | biostudies-arrayexpress

mRNA profiles of 50 HB tumors

Project description:Hepatoblastoma (HB) is the most common liver cancer in children, but few pre-treatment tumors have been molecularly profiled. Consequently, there are no validated prognostic or therapeutic biomarkers for HB patients. We report on molecular analysis of 88 clinically-annotated HB tumors. This analysis pointed to three risk-stratifying molecular subtypes—low, intermediate and high risk—that are characterized by differential activation of hepatic progenitor cell markers and metabolic pathways. High-risk tumors are characterized by high NFE2L2 activity and LIN28B, HMGA2, SALL4 and AFP expression, low let-7 expression and HNF1A activity, and high coordinated expression of oncofetal proteins and stem cell markers. Tests on a 35 HB validation set supported these genes as prognostic biomarkers.

2016-10-10 | GSE75271 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data